Polymyalgia Rheumatica
USMLE Step 1 trap: Expects elevated CK in PMR rather than normal muscle enzymes with elevated inflammatory markers. PMR causes markedly elevated ESR and CRP but normal CK and muscle enzymes, distinguishing it from true myositis.
Polymyalgia Rheumatica (PMR) is an inflammatory condition of older adults (almost always >50, peak >70) that causes aching and stiffness in the shoulder and hip girdle muscles — but critically, it's NOT a true myopathy. On USMLE Step 1, the trap is that students expect elevated muscle enzymes because the complaint sounds muscular. PMR causes no muscle damage, so CK is normal; the elevated inflammatory markers are ESR and CRP. The exam presents this as a classic vignette: elderly patient, bilateral shoulder/hip stiffness worse in the morning, elevated ESR and CRP, normal CK — your job is to resist the reflex to call it polymyositis.
The bigger clinical stakes involve the association with Giant Cell Arteritis (GCA). Up to 50% of GCA patients have PMR, and about 15–20% of PMR patients develop GCA. USMLE Step 1 loves the GCA overlap because it creates a management decision under pressure: if a PMR patient develops new headache, jaw claudication, scalp tenderness, or visual symptoms, you must act immediately. The exam tests whether you know that high-dose steroids come before biopsy — not after.
What makes this topic tricky is the dual-disease logic and the steroid dosing split. PMR uses low-dose prednisone (~15–20 mg/day); GCA requires high-dose (40–60 mg/day) to prevent irreversible vision loss. Students who treat them the same will get burned. The distinction between PMR and inflammatory myositis (like polymyositis) is also a classic Step 1 foil — same symptom pattern, completely different lab findings and mechanism.
Common misconceptions
What the exam tests
- Recognize the classic PMR presentation: bilateral proximal muscle stiffness (shoulders and hips) in a patient over 50, with markedly elevated ESR/CRP but normal CK and muscle enzymes — and distinguish it from true inflammatory myopathies like polymyositis.
- Identify features that suggest concurrent GCA in a PMR patient (new headache, jaw claudication, vision changes, temporal artery tenderness) and know that this is an emergency requiring immediate high-dose steroids, not a workup-first situation.
- Apply the correct steroid dosing for each condition: low-dose prednisone for isolated PMR (~15–20 mg/day) versus high-dose prednisone for GCA (40–60 mg/day), and understand why the difference exists — vision loss prevention.
Can you avoid these mistakes?
Related topics
See how your Anki deck covers this topic.
Upload your deck for a free audit →